Registration - Amendment

ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) for CARIS SCIENCE, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Precision medicine policies. Appropriate regulatory oversight of diagnostic testing. Coverage and reimbursement of Next Generation Sequencing and other technologies.

LobbyistCovered position, as disclosed
AMY JENSEN CUNNIFFE New 99-01 Assistant to the Speaker for Policy; 03-05 Special Assistant to the President for Legislative Affairs

Medicare/Medicaid MMM

Precision medicine policies. Appropriate regulatory oversight of diagnostic testing. Coverage and reimbursement of Next Generation Sequencing and other technologies.

LobbyistCovered position, as disclosed
AMY JENSEN CUNNIFFE New 99-01 Assistant to the Speaker for Policy; 03-05 Special Assistant to the President for Legislative Affairs

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
CARIS LIFE SCIENCES, LTD Cayman Islands Cayman Islands 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.